This calls for improved treatment (e.g., single-dose tafenoquine with G6PD testing) and surveillance strategies (including the detection of SM infections) tackling simultaneously P. falciparum and P. vivax infections if malaria elimination is to be achieved by 2030 as endorsed by the Vietnamese government. Here, G6PD is linked to infection.